In a phase 1 clinical trial of IGF-1 in RTT, improved right-sided alpha band asymmetry on electroencephalogram (EEG), a biomarker of anxiety and mood disorders, was mildly associated with lowered ADAMS scores in 5 out of 6 participants [16]. Here, IGF1 is linked to mood disorder.